Citation: Guosheng He, Qingce Zang, Zhenran Si, Xiaojing Zhang, Lingzhi Wang, Zhijun Qin, Jingshu Hu, Fei Li, Can Wang, Hengyu Wang, Kexin Chang, Ruiping Zhang, Xiuwei Chen. Spatially resolved profiling of reprogrammed metabolism in ovarian cancer using ambient mass spectrometry imaging[J]. Chinese Chemical Letters, ;2026, 37(11): 112564. doi: 10.1016/j.cclet.2026.112564 shu

Spatially resolved profiling of reprogrammed metabolism in ovarian cancer using ambient mass spectrometry imaging

Guosheng He ^{a, 1} ,
Qingce Zang ^{b, 1} ,
Zhenran Si ^b ,
Xiaojing Zhang ^b ,
Lingzhi Wang ^b ,
Zhijun Qin ^a ,
Jingshu Hu ^a ,
Fei Li ^b ,
Can Wang ^a ,
Hengyu Wang ^a ,
Kexin Chang ^a ,
Ruiping Zhang ^{b, *,} ,
Xiuwei Chen ^{a, *,}

a.
Department of Gynecologic Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China
b.
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China

rpzhang@imm.ac.cn

1427@hrbmu.edu.cn

Received Date: 15 August 2025
Revised Date: 22 January 2026
Accepted Date: 28 February 2026
Available Online: 1 March 2026

Figures(4)

Ovarian cancer is a lethal gynecological malignancy in adult women. Metabolic reprogramming not only facilitates the survival and proliferation of ovarian cancer cells but also contributes to metastasis and chemoresistance acquisition. Spatially resolved profiling of aberrant metabolic patterns in ovarian cancer tissues can reveal tumor-specific metabolic alterations underlying cancer development and progression. Here, we employed ambient airflow-assisted desorption electrospray ionization mass spectrometry imaging (AFADESI-MSI) to characterize the metabolic profiles of high-grade serous ovarian carcinoma and normal ovarian tissues. AFADESI-MSI enabled clear visualization of a broad range of small molecules, spanning from polar metabolites to lipids. Spatial mapping revealed tumor-specific metabolite accumulation or depletion, with distinct patterns aligned to histological boundaries. Tumor and non-tumor regions were distinctly demarcated based exclusively on region-specific metabolite distributions. Spatially resolved metabolomics analysis identified 127 differential metabolites, predominantly lipids (69.29%), including fatty acyls, glycerophospholipids, steroids, and glycerolipids. The dysregulated metabolic pathways encompassed unsaturated fatty acid biosynthesis, steroid hormone metabolism, glycerophospholipid metabolism, and amino acid metabolism. Overall, this technique uncovered tumor-associated metabolic alterations, demonstrating potential to augment histological diagnosis and identify therapeutic metabolic vulnerabilities in ovarian cancer.
- Mass spectrometry imaging,
- Spatial metabolomics,
- Ovarian cancer,
- Metabolic reprogramming,
- Dysregulated metabolic pathway
1. [1]
  N.N. Pavlova, J. Zhu, C.B. Thompson, Cell Metab. 34 (2022) 355–377. doi: 10.1016/j.cmet.2022.01.007
2. [2]
  B. Faubert, A. Solmonson, R.J. DeBerardinis, Science 368 (2020) eaaw5473. doi: 10.1126/science.aaw5473
3. [3]
  S. Nong, X. Han, Y. Xiang, et al., MedComm 4 (2023) e218. doi: 10.1002/mco2.218
4. [4]
  Y. Zhang, Y. Wang, G. Zhao, et al., Pharmacol. Ther. 245 (2023) 108413. doi: 10.1016/j.pharmthera.2023.108413
5. [5]
  A. Tan, X. Ma, Chin. Chem. Lett. 35 (2024) 109276. doi: 10.1016/j.cclet.2023.109276
6. [6]
  C.J. Chen, D.Y. Lee, J. Yu, et al., Mass Spectrom. Rev. 42 (2023) 2349–2378. doi: 10.1002/mas.21785
7. [7]
  A.R. Buchberger, K. DeLaney, J. Johnson, et al., Anal. Chem. 90 (2017) 240–265.
8. [8]
  J. Chen, P. Xie, P. Wu, et al., Chin. Chem. Lett. 35 (2024) 108895. doi: 10.1016/j.cclet.2023.108895
9. [9]
  S. Guenther, L.J. Muirhead, A.V.M. Speller, et al., Cancer Res. 75 (2015) 1828–1837.
10. [10]
  Q. Zang, C. Sun, X. Chu, et al., Anal. Chim. Acta 1155 (2021) 338342. doi: 10.1016/j.aca.2021.338342
11. [11]
  X. Ma, F.M. Fernández, Mass Spectrom. Rev. 43 (2024) 235–268. doi: 10.1002/mas.21804
12. [12]
  C. Sun, T. Li, X. Song, et al., Proc. Natl. Acad. Sci. U. S. A. 116 (2019) 52–57. doi: 10.1073/pnas.1808950116
13. [13]
  C. Sun, A. Wang, Y. Zhou, et al., Nat. Commun. 14 (2023) 2692. doi: 10.1038/s41467-023-38360-5
14. [14]
  B. Han, R. Zheng, H. Zeng, et al., J. Natl. Cancer Cent. 4 (2024) 47–53.
15. [15]
  M. Sans, K. Gharpure, R. Tibshirani, et al., Cancer Res. 77 (2017) 2903–2913.
16. [16]
  M.L. Dória, J.S. McKenzie, A. Mroz, et al., Sci. Rep. 6 (2016) 39219. doi: 10.1038/srep39219
17. [17]
  J. He, F. Tang, Z. Luo, et al., Rapid Commun. Mass Spectrom. 25 (2011) 843–850. doi: 10.1002/rcm.4920
18. [18]
  J. He, C. Sun, T. Li, et al., Adv. Sci. 5 (2018) 1800250. doi: 10.1002/advs.201800250
19. [19]
  Y. Zhu, Q. Zang, Z. Luo, et al., Anal. Chem. 94 (2022) 7286–7294. doi: 10.1021/acs.analchem.2c00557
20. [20]
  X. Li, Q. Zang, Y. Zhu, et al., Anal. Chem. 95 (2023) 18691–18696. doi: 10.1021/acs.analchem.3c03765
21. [21]
  J. Liu, Q. Zang, X. Li, et al., Chin. Chem. Lett. 34 (2023) 108322. doi: 10.1016/j.cclet.2023.108322
22. [22]
  J. He, L. Huang, R. Tian, et al., Anal. Chim. Acta 1015 (2018) 50–57. doi: 10.1016/j.aca.2018.02.030
23. [23]
  C.L. Chen, S.C. Hsu, D.K. Ann, et al., Cancers 13 (2021) 3541. doi: 10.3390/cancers13143541
24. [24]
  H.J. Lusk, M.A. Haughan, T.M. Bergsten, et al., Cancer Res. Commun. 5 (2025) 569–579. doi: 10.1158/2767-9764.crc-24-0532
25. [25]
  S.K. Tan, H.Y. Hougen, J.R. Merchan, et al., Nat. Rev. Urol. 20 (2023) 48–60. doi: 10.1038/s41585-022-00654-6
26. [26]
  A.R. Terry, N. Hay, Trends Pharmacol. Sci. 45 (2024) 537–551. doi: 10.1016/j.tips.2024.04.007
27. [27]
  M. Schwaiger-Haber, E. Stancliffe, D.S. Anbukumar, et al., Nat. Commun. 14 (2023) 2876. doi: 10.1038/s41467-023-38403-x
28. [28]
  C. Cheng, F. Geng, X. Cheng, et al., Cancer Commun 38 (2018) 27. doi: 10.1186/s40880-018-0301-4
29. [29]
  R.R. Chen, M.M.H. Yung, Y. Xuan, et al., Commun. Biol. 2 (2019) 281. doi: 10.1007/978-1-4939-8910-2_21
30. [30]
  Y. Ma, S.M. Temkin, A.M. Hawkridge, et al., Cancer Lett. 435 (2018) 92–100. doi: 10.1016/j.canlet.2018.08.006
31. [31]
  R. Tang, Y. Zhu, L. Chen, et al., J. Proteomics 307 (2024) 105261. doi: 10.1016/j.jprot.2024.105261
32. [32]
  Z. Peng, Y. Chang, J. Fan, et al., Cancer Lett. 497 (2021) 165–177. doi: 10.1016/j.canlet.2020.10.021
33. [33]
  J. Rong, G. Sun, J. Zhu, et al., J. Pharm. Biomed. Anal. 253 (2025) 116559. doi: 10.1016/j.jpba.2024.116559
34. [34]
  H.S. Ahn, J. Yeom, J. Yu, et al., Cancers (Basel) 12 (2020) 3447. doi: 10.3390/cancers12113447
35. [35]
  A. Tokareva, M. Iurova, N. Starodubtseva, et al., Int. J. Mol. Sci. 26 (2025) 6630. doi: 10.3390/ijms26146630
36. [36]
  X. Li, R. Guo, G. Yang, et al., J. Steroid Biochem. Mol. Biol. 253 (2025) 106816. doi: 10.1016/j.jsbmb.2025.106816
37. [37]
  J.A. Olzmann, P. Carvalho, Nat. Rev. Mol. Cell Biol. 20 (2019) 137–155. doi: 10.1038/s41580-018-0085-z
1. [1]
  Chao Zhao , Chenyu Gao , Zhiyi Yang , Tianyou Cao , Qian Luo , Zhijun Zhang . Whole brain lipid dyshomeostasis in depressive-like behavior young adult rats: Mapping by mass spectrometry imaging-based spatial omics. Chinese Chemical Letters, 2025, 36(10): 111089-. doi: 10.1016/j.cclet.2025.111089
2. [2]
  Jing Chen , Peisi Xie , Pengfei Wu , Yu He , Zian Lin , Zongwei Cai . MALDI coupled with laser-postionization and trapped ion mobility spectrometry contribute to the enhanced detection of lipids in cancer cell spheroids. Chinese Chemical Letters, 2024, 35(4): 108895-. doi: 10.1016/j.cclet.2023.108895
3. [3]
  Yue Xu , Lingzhi Wang , Liu Yang , Renliang Xue , Haowen Zhu , Qifeng Liu , Xueqi Lv , Ruiping Zhang , Jun Tu , Qingce Zang , Yinghong Wang . Spatial metabolomics combined with transcriptomics to reveal heterogeneous metabolism and drug response in the heart of rats with heart failure. Chinese Chemical Letters, 2025, 36(7): 110958-. doi: 10.1016/j.cclet.2025.110958
4. [4]
  Xiaopin Lai , Hao Xu , Xing Chen , Jiayi Ke , Shu-Hai Lin . From innovation to application: Pioneering advances in mass spectrometry imaging for spatially resolved single-cell omics. Chinese Chemical Letters, 2026, 37(6): 111932-. doi: 10.1016/j.cclet.2025.111932
5. [5]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
6. [6]
  Dandan Wang , Xiaoyu Ma , Yijin Zhao , Wenting Zou , Hua Wang , Yang Gao , Shimeng Wan , Jian Ni , Lilan Xin , Hai-Bing Zhou , Hongbing Cai , Chune Dong . The discovery of acyl thiourea derivatives as potent hydrophobic tagging degraders targeting SIRT2 for the treatment of ovarian cancer. Chinese Chemical Letters, 2026, 37(4): 111143-. doi: 10.1016/j.cclet.2025.111143
7. [7]
  Yu-Qi Cao , Ying-Jie Lu , Li Zhang , Jing Zhang , Yin-Long Guo . Vacuum promoted on-tissue derivatization strategy: Unravelling spatial distribution of glycerides on tissue. Chinese Chemical Letters, 2024, 35(12): 109788-. doi: 10.1016/j.cclet.2024.109788
8. [8]
  Shuai Guo , Kening Li , Bin Li . Parallel on-tissue chemical derivatization for enhanced molecular annotation of spatial carbonyl submetabolome. Chinese Chemical Letters, 2025, 36(6): 110366-. doi: 10.1016/j.cclet.2024.110366
9. [9]
  Boyuan Liu , Zixu Liu , Ping Wang , Yu Zhang , Haibing He , Tian Yin , Jingxin Gou , Xing Tang . Nanomedicine-based targeting delivery systems for peritoneal cavity localized therapy: A promising treatment of ovarian cancer and its peritoneal metastasis. Chinese Chemical Letters, 2025, 36(6): 110229-. doi: 10.1016/j.cclet.2024.110229
10. [10]
  Yanhua Chen , Xian Ding , Jun Zhou , Zhaoying Wang , Yunhai Bo , Ying Hu , Qingce Zang , Jing Xu , Ruiping Zhang , Jiuming He , Fen Yang , Zeper Abliz . Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis. Chinese Chemical Letters, 2025, 36(1): 110351-. doi: 10.1016/j.cclet.2024.110351
11. [11]
  Qianqian Chen , Ziheng Xu , Jiayi Mu , Xiujuan Hong , Yanqin Huang , Jiekai Yu , Ying Yuan , Ning Zhu , Cheng Guo . Urine metabolic profiling and discovery of potential biomarkers for colorectal cancer using liquid chromatography-high resolution mass spectrometry. Chinese Chemical Letters, 2026, 37(8): 112327-. doi: 10.1016/j.cclet.2025.112327
12. [12]
  Meng Yu , Yanhe Zhou , Guanlin Xiao , Xinyi Jiang , Xiangyi Wang , Tong Li , Jianpeng Huang , Jiamin Gao , Junwen Shi , Xiuli Gao , Zeper Abliz , Jiuming He . A high-definition spatially resolved metabolomics method to illuminate the metabolic specificity and interconnection across mouse brain. Chinese Chemical Letters, 2026, 37(1): 111153-. doi: 10.1016/j.cclet.2025.111153
13. [13]
  Hao Li , Hanzhi Lu , Linlin Hu , Xueli Zhang , Hua Shao , Fulun Li , Yanfei Shen . Dynamic surface-enhanced Raman spectroscopy-based metabolic profiling: A novel pathway to overcoming antifungal resistance. Chinese Chemical Letters, 2025, 36(7): 110342-. doi: 10.1016/j.cclet.2024.110342
14. [14]
  Haiyan Lu , Jiayue Ye , Yiping Wei , Hua Zhang , Konstantin Chingin , Vladimir Frankevich , Huanwen Chen . Tracing molecular margins of lung cancer by internal extractive electrospray ionization mass spectrometry. Chinese Chemical Letters, 2025, 36(2): 110077-. doi: 10.1016/j.cclet.2024.110077
15. [15]
  Keqiang Shi , Xiujuan Hong , Dongyan Xu , Tao Pan , Huiwen Wang , Hongru Feng , Cheng Guo , Yuanjiang Pan . Analysis of RNA modifications in peripheral white blood cells from breast cancer patients by mass spectrometry. Chinese Chemical Letters, 2025, 36(3): 110079-. doi: 10.1016/j.cclet.2024.110079
16. [16]
  Jing Guo , Zhi-Guo Lu , Rui-Chen Zhao , Bao-Ku Li , Xin Zhang . Nucleic acid therapy for metabolic-related diseases. Chinese Chemical Letters, 2025, 36(3): 109875-. doi: 10.1016/j.cclet.2024.109875
17. [17]
  Peisi Xie , Jing Chen , Yongjun Xia , Zongwei Cai . MALDI and MALDI-2 mass spectrometry imaging contribute to revealing the alternations in lipid metabolism in germinating soybean seeds. Chinese Chemical Letters, 2025, 36(8): 110595-. doi: 10.1016/j.cclet.2024.110595
18. [18]
  Fukui Shen , Yuqing Zhang , Guoqing Luan , Kaixue Zhang , Zhenzhen Wang , Yunhao Luo , Yuanyuan Hou , Gang Bai . Revealing drug targets with multimodal bioorthogonal AMPD probes through visual metabolic labeling. Chinese Chemical Letters, 2024, 35(12): 109646-. doi: 10.1016/j.cclet.2024.109646
19. [19]
  Qiongqiong Wan , Zhourui Zhang , Mengmeng Zhao , Xianqin Ruan , Yanhong Hao , Jiajun Deng , Yunlang She , Minglei Yang , Yongxiang Song , Feng Jin , Ailin Wei , Sheng Zhong , Jie Zheng , Dong Xie , Suming Chen . Efficient diagnosis of benign and malignant pulmonary nodules based on Nano-zero-valent iron enhanced serum metabolic fingerprinting. Chinese Chemical Letters, 2025, 36(10): 110794-. doi: 10.1016/j.cclet.2024.110794
20. [20]
  Shunping Zang , Jia Ke , Hanbing Zheng , Qing Liu , Benhua Wang , Minhuan Lan , Xiangzhi Song . Visualization of copper metabolic fluctuations across various stages of Parkinson’s disease by a near-infrared fluorescent sensor. Chinese Chemical Letters, 2026, 37(7): 111822-. doi: 10.1016/j.cclet.2025.111822

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(37)
HTML views(3)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142